Grazoprevir CAS:1350514-68-9

Grazoprevir  CAS:1350514-68-9
Product Details

Product Information

CAS NO.1350514-68-9 1.png
Product NameGrazoprevir
Molecular Weight766.9
Spec / Purity98%min
Supply Capacity
DetailsGrazoprevir (MK-5172) is an experimental drug for the treatment of hepatitis C. It is currently in Phase III trials, following promising results in Phase II when used in combination with the NS5A replication complex inhibitor elbasvir, either with or without ribavirin. Grazoprevir is a second generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets. It has good activity against a range of HCV genotype variants, including some that are resistant to most currently used antiviral medications.

If you are going to consult the information about grazoprevir cas:1350514-68-9 from one of the leading Bioactive Molecules manufacturers and suppliers in China, It is always at your service.